Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016, Article ID 4656539, 10 pages
http://dx.doi.org/10.1155/2016/4656539
Research Article

Dynamic Tracking of Injected Mesenchymal Stem Cells after Myocardial Infarction in Rats: A Serial 7T MRI Study

1Department of Radiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
2Department of Ultrasound, Anzhen Hospital, Beijing 100029, China

Received 7 May 2016; Accepted 25 July 2016

Academic Editor: Ping Wang

Copyright © 2016 Xiuyu Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. F. Pittenger and B. J. Martin, “Mesenchymal stem cells and their potential as cardiac therapeutics,” Circulation Research, vol. 95, no. 1, pp. 9–20, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. T. J. Povsic and C. M. O'Connor, “Cell therapy for heart failure: the need for a new therapeutic strategy,” Expert Review of Cardiovascular Therapy, vol. 8, no. 8, pp. 1107–1126, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Stamm, B. Westphal, H.-D. Kleine et al., “Autologous bone-marrow stem-cell transplantation for myocardial regeneration,” The Lancet, vol. 361, no. 9351, pp. 45–46, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Menasché, A. A. Hagège, J.-T. Vilquin et al., “Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction,” Journal of the American College of Cardiology, vol. 41, no. 7, pp. 1078–1083, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Fernández-Avilés, J. A. San Román, J. García-Frade et al., “Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction,” Circulation Research, vol. 95, no. 7, pp. 742–748, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. K. C. Wollert, G. P. Meyer, J. Lotz et al., “Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial,” The Lancet, vol. 364, no. 9429, pp. 141–148, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Janssens, C. Dubois, J. Bogaert et al., “Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial,” The Lancet, vol. 367, no. 9505, pp. 113–121, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Lunde, S. Solheim, S. Aakhus et al., “Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction,” The New England Journal of Medicine, vol. 355, no. 12, pp. 1199–1209, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Uemura, M. Xu, N. Ahmad, and M. Ashraf, “Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling,” Circulation Research, vol. 98, no. 11, pp. 1414–1421, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. E. L. Olivares, R. H. Costa-e-Sousa, J. P. S. Werneck-de-Castro et al., “Cellular cardiomyoplasty in large myocardial infarction: can the beneficial effect be enhanced by ACE-inhibitor therapy?” European Journal of Heart Failure, vol. 9, no. 6-7, pp. 558–567, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Peng, K. Yang, P. Xiang et al., “Effect of transplantation with autologous bone marrow stem cells on acute myocardial infarction,” International Journal of Cardiology, vol. 162, no. 3, pp. 158–165, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Nagaya, T. Fujii, T. Iwase et al., “Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 287, no. 6, pp. H2670–H2676, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Amsalem, Y. Mardor, M. S. Feinberg et al., “Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium,” Circulation, vol. 116, no. 11, pp. I38–I45, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Buck, P. Hunold, K. U. Wentz, W. Tkalec, H. Joachim Nesser, and R. Erbel, “Tomographic three-dimensional echocardiographic determination of chamber size and systolic function in patients with left ventricular aneurysm: comparison to magnetic resonance imaging, cineventriculography, and two- dimensional echocardiography,” Circulation, vol. 96, no. 12, pp. 4286–4297, 1997. View at Publisher · View at Google Scholar · View at Scopus
  15. F. Grothues, G. C. Smith, J. C. C. Moon et al., “Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy,” The American Journal of Cardiology, vol. 90, no. 1, pp. 29–34, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. D. J. Stuckey, C. A. Carr, D. J. Tyler, and K. Clarke, “Cine-MRI versus two-dimensional echocardiography to measure in vivo left ventricular function in rat heart,” NMR in Biomedicine, vol. 21, no. 7, pp. 765–772, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Ma, H. Cheng, M. Lu et al., “Magnetic resonance imaging with superparamagnetic iron oxide fails to track the long-term fate of mesenchymal stem cells transplanted into heart,” Scientific Reports, vol. 5, article 9058, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. E. M. Winter, B. Hogers, L. M. van der Graaf, A. C. Gittenberger-de Groot, R. E. Poelmann, and L. van der Weerd, “Cell tracking using iron oxide fails to distinguish dead from living transplanted cells in the infarcted heart,” Magnetic Resonance in Medicine, vol. 63, no. 3, pp. 817–821, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. W. Wang, Q. Jiang, H. Zhang et al., “Intravenous administration of bone marrow mesenchymal stromal cells is safe for the lung in a chronic myocardial infarction model,” Regenerative Medicine, vol. 6, no. 2, pp. 179–190, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. J. M. Hill, A. J. Dick, V. K. Raman et al., “Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells,” Circulation, vol. 108, no. 8, pp. 1009–1014, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Yang, A. Schumacher, Y. Yang et al., “Monitoring bone marrow-originated mesenchymal stem cell traffic to myocardial infarction sites using magnetic resonance imaging,” Magnetic Resonance in Medicine, vol. 65, no. 5, pp. 1430–1436, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. G. P. Meyer, K. C. Wollert, J. Lotz et al., “Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (Bone marrow transfer to enhance ST-elevation infarct regeneration) trial,” Circulation, vol. 113, no. 10, pp. 1287–1294, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Zhang, J. Ge, A. Sun et al., “Comparison of various kinds of bone marrow stem cells for the repair of infarcted myocardium: single clonally purified non-hematopoietic mesenchymal stem cells serve as a superior source,” Journal of Cellular Biochemistry, vol. 99, no. 4, pp. 1132–1147, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. L. B. Balsam, A. J. Wagers, J. L. Christensen, T. Kofidis, I. L. Weissmann, and R. C. Robbins, “Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium,” Nature, vol. 428, no. 6983, pp. 668–673, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. A. A. Kocher, M. D. Schuster, M. J. Szabolcs et al., “Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function,” Nature Medicine, vol. 7, no. 4, pp. 430–436, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. W. Dai, S. L. Hale, B. J. Martin et al., “Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects,” Circulation, vol. 112, no. 2, pp. 214–223, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Deten, H. C. Volz, S. Clamors et al., “Hematopoietic stem cells do not repair the infarcted mouse heart,” Cardiovascular Research, vol. 65, no. 1, pp. 52–63, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. A. A. Mangi, N. Noiseux, D. Kong et al., “Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts,” Nature Medicine, vol. 9, no. 9, pp. 1195–1201, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. X. Hu, J. Wang, J. Chen et al., “Optimal temporal delivery of bone marrow mesenchymal stem cells in rats with myocardial infarction,” European Journal of Cardio-Thoracic Surgery, vol. 31, no. 3, pp. 438–443, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. S. L. M. A. Beeres, F. M. Bengel, J. Bartunek et al., “Role of imaging in cardiac stem cell therapy,” Journal of the American College of Cardiology, vol. 49, no. 11, pp. 1137–1148, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. V. Fuster, J. Sanz, J. F. Viles-Gonzalez, and S. Rajagopalan, “The utility of magnetic resonance imaging in cardiac tissue regeneration trials,” Nature Clinical Practice Cardiovascular Medicine, vol. 3, supplement 1, pp. S2–S7, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. C. A. Carr, D. J. Stuckey, L. Tatton et al., “Bone marrow-derived stromal cells home to and remain in the infarcted rat heart but fail to improve function: an in vivo cine-MRI study,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 295, no. 2, pp. H533–H542, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Drey, Y.-H. Choi, K. Neef et al., “Noninvasive in vivo tracking of mesenchymal stem cells and evaluation of cell therapeutic effects in a murine model using a clinical 3.0 T MRI,” Cell Transplantation, vol. 22, no. 11, pp. 1971–1980, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. D. L. Kraitchman, A. W. Heldman, E. Atalar et al., “In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction,” Circulation, vol. 107, no. 18, pp. 2290–2293, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. O. Agbulut, S. Vandervelde, N. Al Attar et al., “Comparison of human skeletal myoblasts and bone marrow-derived CD133+ progenitors for the repair of infarcted myocardium,” Journal of the American College of Cardiology, vol. 44, no. 2, pp. 458–463, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Cai, R. Shen, L. Song et al., “Bone Marrow Mesenchymal Stem Cells (BM-MSCs) improve heart function in swine myocardial infarction model through paracrine effects,” Scientific Reports, vol. 6, Article ID 28250, 2016. View at Publisher · View at Google Scholar
  37. H.-F. Tse, C.-W. Siu, S.-G. Zhu et al., “Paracrine effects of direct intramyocardial implantation of bone marrow derived cells to enhance neovascularization in chronic ischaemic myocardium,” European Journal of Heart Failure, vol. 9, no. 8, pp. 747–753, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Kinnaird, E. S. Burnett, M. S. Shou et al., “Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms,” Circulation, vol. 109, no. 12, pp. 1543–1549, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Gnecchi, H. He, O. D. Liang et al., “Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells,” Nature Medicine, vol. 11, no. 4, pp. 367–368, 2005. View at Publisher · View at Google Scholar · View at Scopus